236 related articles for article (PubMed ID: 36658503)
1. The vaginal microbiota of women living with HIV on suppressive antiretroviral therapy and its relation to high-risk human papillomavirus infection.
Chávez-Torres M; Gómez-Palacio-Schjetnan M; Reyes-Terán G; Briceño O; Ávila-Ríos S; Romero-Mora KA; Pinto-Cardoso S
BMC Microbiol; 2023 Jan; 23(1):21. PubMed ID: 36658503
[TBL] [Abstract][Full Text] [Related]
2. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa.
Chachage M; Parikh AP; Mahenge A; Bahemana E; Mnkai J; Mbuya W; Mcharo R; Maganga L; Mwamwaja J; Gervas R; Kibuuka H; Maswai J; Singoei V; Iroezindu M; Fasina A; Esber A; Dear N; Imbach M; Crowell TA; Hern J; Song X; Hoelscher M; Polyak CS; Ake JA; Geldmacher C;
AIDS; 2023 Mar; 37(4):625-635. PubMed ID: 36398743
[TBL] [Abstract][Full Text] [Related]
3. Vaginal microbiota associated with oncogenic HPV in a cohort of HPV-vaccinated women living with HIV.
McClymont E; Albert AY; Wang C; Dos Santos SJ; Coutlée F; Lee M; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Yudin MH; Harris M; Wobeser W; Hill JE; Money DM;
Int J STD AIDS; 2022 Aug; 33(9):847-855. PubMed ID: 35775280
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
[TBL] [Abstract][Full Text] [Related]
5. The vaginal microbiota among the different status of human papillomavirus infection and bacterial vaginosis.
Liu Y; Li T; Guo R; Chen T; Wang S; Wu D; Li J; Liu Z; Zhao Y; Yin J; Qin J; Sun L; Chen W
J Med Virol; 2023 Mar; 95(3):e28595. PubMed ID: 36811337
[TBL] [Abstract][Full Text] [Related]
6. The vaginal microbiota, high-risk human papillomavirus infection, and cervical cytology: results from a population-based study.
McKee KS; Carter KA; Bassis C; Young VB; Reed B; Harper DM; Ruffin MT; Bell JD
Gynecol Pelvic Med; 2020 Sep; 3():. PubMed ID: 35252846
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
[TBL] [Abstract][Full Text] [Related]
8. Veteran Women Living With Human Immunodeficiency Virus Have Increased Risk of Human Papillomavirus (HPV)-Associated Genital Tract Cancers.
Clark E; Chen L; Dong Y; Raychaudhury S; White D; Kramer JR; Chiao E
Clin Infect Dis; 2021 May; 72(9):e359-e366. PubMed ID: 32785700
[TBL] [Abstract][Full Text] [Related]
9. Detection of HPV DNA in vaginal samples self-collected by women living with HIV treated through the Brazilian public health system: Prevalence and analysis of risk factors.
Silveira MFD; Buffarini R; Gaspar PC; Machado HM; Bazzo ML; Scherer A; Colusso ÁL; Travassos AGÁ; Arakaki-Sanchez D; Baia-da-Silva DC; Oliveira EC; Zago IR; Moura MA; Lacerda MVG; Martins SM; Reuter T; Pinto VM; Perini W; Pereira GFM; Miranda AE
Rev Soc Bras Med Trop; 2023; 56():e02772023. PubMed ID: 37820103
[TBL] [Abstract][Full Text] [Related]
10. Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.
Nieves-Ramírez ME; Partida-Rodríguez O; Moran P; Serrano-Vázquez A; Pérez-Juárez H; Pérez-Rodríguez ME; Arrieta MC; Ximénez-García C; Finlay BB
Microbiol Spectr; 2021 Oct; 9(2):e0014321. PubMed ID: 34643408
[TBL] [Abstract][Full Text] [Related]
11. Altered Vaginal Microbiota Composition Correlates With Human Papillomavirus and Mucosal Immune Responses in Women With Symptomatic Cervical Ectopy.
López-Filloy M; Cortez FJ; Gheit T; Cruz Y Cruz O; Cruz-Talonia F; Chávez-Torres M; Arteaga-Gómez C; Mancilla-Herrera I; Montesinos JJ; Cortés-Morales VA; Aguilar C; Tommasino M; Pinto-Cardoso S; Rocha-Zavaleta L
Front Cell Infect Microbiol; 2022; 12():884272. PubMed ID: 35656032
[TBL] [Abstract][Full Text] [Related]
12. Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy.
Nakisige C; Adams SV; Namirembe C; Okoche L; Ferrenberg J; Towlerton A; Larsen A; Orem J; Casper C; Frenkel L; Uldrick TS
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):333-342. PubMed ID: 35195571
[TBL] [Abstract][Full Text] [Related]
13. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies.
Zhao R; Sekar P; Bennis SL; Kulasingam S
Prev Med; 2023 May; 170():107494. PubMed ID: 37001607
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus prevalence in pregnant women living with human immunodeficiency virus infection: a scoping review of the literature.
Metz CK; Skof AS; Henrich W; Sehouli J; Kaufmann AM; Rohr I
J Perinat Med; 2024 Jan; 52(1):1-13. PubMed ID: 37540166
[TBL] [Abstract][Full Text] [Related]
16. HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.
Gilles C; Rozenberg S; Buxant F; Manigart Y; de Wind R; Houte KV; Vandenbroeck D; Delforge M; Konopnicki D
Vaccine; 2022 Nov; 40(50):7230-7237. PubMed ID: 36328880
[TBL] [Abstract][Full Text] [Related]
17. HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV.
McClymont E; Tan DH; Bondy S; Albert A; Coutlée F; Lee M; Walmsley S; Ogilvie G; Money D
Int J STD AIDS; 2023 May; 34(6):402-407. PubMed ID: 36702811
[TBL] [Abstract][Full Text] [Related]
18. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rönsholt FF; Johansen IS; Pedersen G; Gaardsting A; Nielsen LN; Bonde J; Lebech AM
J Clin Virol; 2018 Aug; 105():64-71. PubMed ID: 29906660
[TBL] [Abstract][Full Text] [Related]
20. Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology.
Grover S; Seckar T; Gao L; Bhatia R; Lin X; Zetola N; Ramogola-Masire D; Robertson E
Tumour Virus Res; 2023 Jun; 15():200262. PubMed ID: 37209888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
